PGEN logo

PGEN
Precigen Inc

8,918
Mkt Cap
$1.4B
Volume
2.15M
52W High
$5.47
52W Low
$1.23
PE Ratio
-2.83
PGEN Fundamentals
Price
$3.90
Prev Close
$3.96
Open
$3.97
50D MA
$3.88
Beta
1.76
Avg. Volume
5.64M
EPS (Annual)
-$1.37
P/B
67.02
Rev/Employee
$60,525.00
$1,308.69
Loading...
Loading...
News
all
press releases
Precigen (NASDAQ:PGEN) Trading Up 7.5% - Still a Buy?
Precigen (NASDAQ:PGEN) Trading Up 7.5% - What's Next...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Precigen (NASDAQ:PGEN) Trading Down 5.6% - Here's Why
Precigen (NASDAQ:PGEN) Trading Down 5.6% - Here's Why...
MarketBeat·9d ago
News Placeholder
Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 4,772,781 Shares of Stock
Precigen, Inc. (NASDAQ:PGEN - Get Free Report) Director Randal Kirk sold 4,772,781 shares of the firm's stock in a transaction on Monday, March 30th. The shares were sold at an average price of $3.30, for a total value of $15,750,177.30. Following the transaction, the director owned 302,213 shares...
MarketBeat·21d ago
News Placeholder
Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Hold" from Brokerages
Shares of Precigen, Inc. (NASDAQ:PGEN - Get Free Report) have been assigned a consensus recommendation of "Hold" from the seven research firms that are currently covering the stock, MarketBeat...
MarketBeat·22d ago
News Placeholder
Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat
Precigen (NASDAQ:PGEN) executives used a fireside chat hosted by H.C. Wainwright to outline the company's transition into a commercial-stage organization following the FDA approval of Papzimeos, the first immunotherapy approved for adults with recurrent respiratory papillomatosis (RRP). The discussi...
MarketBeat·23d ago
News Placeholder
Precigen (NASDAQ:PGEN) Stock Price Up 11.2% - What's Next?
Precigen (NASDAQ:PGEN) Trading Up 11.2% - What's Next...
MarketBeat·23d ago
News Placeholder
Precigen (NASDAQ:PGEN) Shares Down 9% - Time to Sell?
Precigen (NASDAQ:PGEN) Stock Price Down 9% - Should You Sell...
MarketBeat·24d ago
News Placeholder
Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31
Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31 Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31 PR Newswire GERMANTOWN, Md., March 30, 2026 GERMANTOWN, Md., March 30, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage...
PR Newswire·24d ago
News Placeholder
HC Wainwright Estimates Precigen's Q1 Earnings (NASDAQ:PGEN)
Precigen, Inc. (NASDAQ:PGEN - Free Report) - Research analysts at HC Wainwright boosted their Q1 2026 EPS estimates for Precigen in a research report issued on Thursday, March 26th. HC Wainwright...
MarketBeat·25d ago
News Placeholder
Precigen (NASDAQ:PGEN) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised Precigen from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·27d ago
<
1
2
...
>

Latest PGEN News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.